About Us
We are a joung bio-technology start-up working the unqiue bio-technology platform Adena Intel that leverages recent advancements in artifical intelligence to create novel biopharmaceutical drugs. Based in Zurich (CH), our mission is to
- Identify novel drug candidates based on AI recommendation.
- Rapid drug candidate evaluation through protein simulaton.
- Leverage existing pharmaceuticals for novel conditions.
Data Sets of on the market drugs analyzed by our Adena Intel platform.
Projects to evaluate novel drug candidates suggested by our Adena Intel platform
Years of experience in the bio-technology area across our team
Mission
Leverage Artifical Intelligence
Leverage the power of artifical intelligence for drug candidate research.
Testimonials
Magnam dolores commodi suscipit eum quidem consectetur velit
Matt Liton
Researcher
This team combines a unique experience with outstanding ideas. Their approach could be a game changer for the bio-technology industry!
John Larson
Biomed Entrepreneur
The combination of technological and bio-sience knwoledge in your team massivly impressed me. Can't wait to see the first results!
Team
Andreas Hansen
Chief Executive Officer
Sarah Jhonson
Research Lead
Patrick Spiegel
CTOContact Us
Vesperr
Pioneering Novel Biopharmaceuticals
Maneggstrasse 93
Zurich, ZH 8041, CH
info@adena-bio.com
+41 78 222 42 74